Consultant

President of Waki-Corporation

 Waki-corporation has been established in 2008. 8, as one of medical consulting companies advising strategic planning of product development and comprehensive supporting for a wide range of clinical trials in drug and medical device-relating companies. His extensive experiences on clinical practice in Japan over three decade as well as research studies and teaching in two U.S. State Universities for ten years are very unique and useful in his activities of the company to support the drug development and regulatory affairs in the pharmaceutical companies from medical point of view in Japan and abroad.

Waki-Corporation can also provide various direct services for assisting clinical trials, medical writing, and auditing and safety management.

I have clinically worked as a gynecologist/obstetrician in Japan over three decade. I also studied in research and taught as a medical faculty (Associate Professor) in Dept. of Medicine and Obst/Gyne. Sch.of Medicine, University of Pittsburgh and University of Washington in U.S. for ten years. 

My own research interests include estrogen biosynthesis/metabolism and inhibin during pregnancy, sexual differentiation of hepatic drug-metabolizing enzyme, placental sulfatase deficiency and reproductive endocrinology and oncology. 

My extensive experiences on clinical practice as well as research studies ave extremely influenced to my new jobs as a medical director/ general manager for drug development in the pharmaceutical companies-- Zeneca KK(3 years), Upjohn(2 years) and as a vice president of Japanese CRO(3years). 

In 2000. 8, Waki-Corporation was established by myself as one of medical consulting companies supporting comprehensive services, advising strategic planning of product development, directly assisting clinical trials, medical writing, auditing and safety management. 

I have been a president of "HiMedic Co., Ltd. " from 2002. 5 to 2006. 4 to provide various services in a wide range of different field on drug and medical devices development in preclinical and clinical studies.

I have been working as a business strategy adviser of Takamatsu Intellectual Cluster since 2002 to 2007. and also actively worked as a medical advisor of I'rom Ltd. in 2005 - 2011.

I have worked as a chairman of Central IRB/ERB in clinical Research Tokyo Medical Hospital since 2013.1 to 2015.7, then having continued to work as one of medical staffs In the Hospital to 2018..7.

President of the company can work as a medical advisor/expert closely with internal personnel to enhance the quality and time line of the clinical trials for the drug development.